McClellan’s “Strong FDA” Is Unfazed By Device Appropriations Shortfall
This article was originally published in The Gray Sheet
Executive Summary
FDA is assuring medical device execs that the Bush Administration is united in seeking the additional appropriations required by MDUFMA, but cannot guarantee that funding benchmarks will be met by 2004
You may also be interested in...
FDA Fingerprints On MDUFMA Trigger? MDMA Holds Hill To Funding Targets
A revision of the "trigger" within the Medical Device User Fee & Modernization Act to account for appropriations shortfalls would represent a breach of the original agreement by Congress, FDA and industry, the Medical Device Manufacturers Association contends
FDA Fingerprints On MDUFMA Trigger? MDMA Holds Hill To Funding Targets
A revision of the "trigger" within the Medical Device User Fee & Modernization Act to account for appropriations shortfalls would represent a breach of the original agreement by Congress, FDA and industry, the Medical Device Manufacturers Association contends
User Fees Hiked In FY ’04: Fewer Submissions, Bundling Cited As Factors
PMA submission trends over the next 12 months will help determine whether device user fees in fiscal 2005 continue to rise at the FY 2004 rate